Approach to the Patient with Dermatologic Disease |
|
1 | (1) |
|
Therapeutic Principles in Dermatology |
|
|
|
|
2 | (2) |
|
Treatment of Dermatologic Conditions in Pregnancy |
|
|
4 | (1) |
|
|
|
|
5 | (5) |
|
|
5 | (1) |
|
|
6 | (1) |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
8 | (2) |
|
Papulosquamous Dermatoses |
|
|
10 | (4) |
|
|
10 | (1) |
|
|
11 | (2) |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
14 | (2) |
|
Pigmented Purpuric Dermatoses |
|
|
16 | (1) |
|
|
17 | (1) |
|
Acantholytic Dermatosis (Grover Disease) |
|
|
17 | (1) |
|
|
|
|
18 | (3) |
|
|
21 | (1) |
|
|
22 | (1) |
|
Common Skin and Nail Infections |
|
|
|
Bacterial Skin Infections |
|
|
22 | (4) |
|
|
22 | (1) |
|
Abscesses/Furuncles/Carbuncles |
|
|
23 | (1) |
|
|
23 | (1) |
|
Cellulitis and Erysipelas |
|
|
24 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
Superficial Fungal Infections |
|
|
26 | (1) |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
27 | (4) |
|
|
27 | (2) |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
31 | (1) |
|
|
|
|
31 | (1) |
|
|
32 | (1) |
|
|
32 | (1) |
|
|
32 | (1) |
|
|
|
|
33 | (1) |
|
|
34 | (1) |
|
|
|
|
34 | (1) |
|
Actinic Keratoses and Squamous Cell Carcinoma In Situ |
|
|
35 | (1) |
|
|
36 | (1) |
|
|
37 | (1) |
|
|
37 | (2) |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
41 | (1) |
|
Hypertrophic Scars and Keloids |
|
|
41 | (1) |
|
|
41 | (1) |
|
Epidermal Inclusion Cysts |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
42 | (2) |
|
|
|
|
44 | (1) |
|
Clinical Manifestations and Diagnosis |
|
|
44 | (1) |
|
|
45 | (1) |
|
Autoimmune Bullous Diseases |
|
|
|
Recognizing and Diagnosing Autoimmune Bullous Diseases |
|
|
46 | (2) |
|
|
48 | (1) |
|
|
48 | (1) |
|
Cutaneous Manifestations of Internal Disease |
|
|
|
|
48 | (5) |
|
|
48 | (2) |
|
|
50 | (1) |
|
|
51 | (1) |
|
Purpura and Cutaneous Vasculitis |
|
|
51 | (2) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
Nephrogenic Systemic Fibrosis |
|
|
54 | (1) |
|
Cutaneous Malignancies Following Kidney Transplantation |
|
|
54 | (1) |
|
|
54 | (1) |
|
|
54 | (2) |
|
|
55 | (1) |
|
|
56 | (1) |
|
Inflammatory Bowel Disease |
|
|
56 | (2) |
|
|
57 | (1) |
|
|
58 | (2) |
|
|
58 | (2) |
|
|
60 | (1) |
|
|
60 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
Dermatologic Urgencies and Emergencies |
|
|
|
Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis |
|
|
61 | (3) |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
|
|
65 | (1) |
|
|
66 | (1) |
|
Metabolic Imbalance and Medications |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
Central Centrifugal Cicatricial Alopecia |
|
|
66 | (1) |
|
|
67 | (1) |
|
|
67 | (1) |
|
|
|
|
67 | (1) |
|
|
68 | (1) |
|
Melanonychia and Subungual Melanoma |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
69 | (1) |
|
|
69 | (1) |
|
|
69 | (1) |
|
Disorders of Mucous Membranes |
|
|
|
|
70 | (1) |
|
|
70 | (1) |
|
|
70 | (1) |
|
Leukoplakia and Erythroplakia |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
72 | (1) |
|
|
|
|
72 | (1) |
|
|
73 | (1) |
|
|
74 | (1) |
|
Skin in Aging Populations |
|
|
|
Common Clinical Problems in Older Skin |
|
|
74 | (1) |
|
|
75 | (1) |
|
Dermatologic Diseases of Skin of Color |
|
|
|
Postinflammatory Hypo- or Hyperpigmentation |
|
|
76 | (1) |
|
Common Lesions in Skin of Color |
|
|
76 | (1) |
|
|
76 | (1) |
|
|
77 | (1) |
|
|
77 | (1) |
|
Dermatosis Papulosa Nigra |
|
|
77 | (1) |
|
|
77 | (1) |
|
|
77 | |
Bibliography |
|
78 | (3) |
Self-Assessment Test |
|
81 | (56) |
Index |
|
137 | |
|
Approach to the Patient with Rheumatic Disease |
|
|
|
Inflammatory Versus Noninflammatory Pain |
|
|
1 | (1) |
|
The Musculoskeletal Examination |
|
|
1 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
Extra-Articular Manifestations of Rheumatic Disease |
|
|
3 | (3) |
|
Dermatologic Manifestations |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
5 | (1) |
|
Musculoskeletal and Rheumatic Manifestations |
|
|
5 | (1) |
|
|
6 | (1) |
|
Tests That Measure Inflammation |
|
|
6 | (1) |
|
|
6 | (1) |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
Principles of Therapeutics |
|
|
|
Evaluation of Disease Progression |
|
|
9 | (1) |
|
|
9 | (2) |
|
|
9 | (1) |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
10 | (1) |
|
Disease-Modifying Antirheumatic Drugs |
|
|
11 | (3) |
|
Nonbiologic Disease-Modifying Antirheumatic Drugs |
|
|
11 | (1) |
|
Biologic Disease-Modifying Antirheumatic Drags |
|
|
12 | (2) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
|
Pathophysiology and Risk Factors |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (2) |
|
|
16 | (1) |
|
|
16 | (2) |
|
Complications and Extra-Articular Manifestations |
|
|
18 | (1) |
|
|
19 | (2) |
|
NSAIDs and Corticosteroids |
|
|
20 | (1) |
|
Disease-Modifying Antirheumatic Drugs |
|
|
20 | (1) |
|
|
21 | (1) |
|
Nonpharmacologic Management |
|
|
21 | (1) |
|
Rheumatoid Arthritis and Pregnancy |
|
|
21 | (1) |
|
|
|
|
22 | (1) |
|
|
22 | (1) |
|
Clinical Features and Classification |
|
|
22 | (2) |
|
|
23 | (1) |
|
|
23 | (1) |
|
|
23 | (1) |
|
Diffuse Idiopathic Skeletal Hyperostosis |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
24 | (2) |
|
Nonpharmacologic Interventions |
|
|
24 | (1) |
|
|
25 | (1) |
|
Intra-articular Injection |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
|
|
26 | (1) |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
27 | (1) |
|
|
27 | (1) |
|
|
|
|
28 | (1) |
|
|
28 | (1) |
|
|
28 | (1) |
|
|
28 | (3) |
|
|
29 | (1) |
|
|
30 | (1) |
|
Inflammatory Bowel Disease-Associated Arthritis |
|
|
30 | (1) |
|
|
30 | (1) |
|
|
31 | (2) |
|
|
32 | (1) |
|
|
32 | (1) |
|
|
33 | (2) |
|
|
33 | (1) |
|
|
34 | (1) |
|
|
34 | (1) |
|
Systemic Lupus Erythematosus |
|
|
|
|
35 | (1) |
|
|
35 | (1) |
|
|
35 | (3) |
|
Mucocutaneous Manifestations |
|
|
35 | (1) |
|
Musculoskeletal Manifestations |
|
|
35 | (1) |
|
|
36 | (1) |
|
Neurologic Manifestations |
|
|
36 | (1) |
|
Cardiovascular Manifestations |
|
|
37 | (1) |
|
|
37 | (1) |
|
Hematologic Manifestations |
|
|
37 | (1) |
|
Gastrointestinal Manifestations |
|
|
37 | (1) |
|
|
38 | (1) |
|
|
38 | (2) |
|
|
39 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
41 | (1) |
|
|
|
Pathophysiology and Epidemiology |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
41 | (1) |
|
Clinical Manifestations and Management |
|
|
42 | (3) |
|
|
42 | (1) |
|
Musculoskeletal Manifestations |
|
|
43 | (1) |
|
|
43 | (1) |
|
Gastrointestinal Manifestations |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
Scleroderma Spectrum Disorders |
|
|
45 | (1) |
|
Pregnancy and Systemic Sclerosis |
|
|
45 | (1) |
|
|
|
Epidemiology and Pathophysiology |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
47 | (1) |
|
Mixed Connective Tissue Disease |
|
|
|
|
47 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
Crystal-Induced Arthropathies |
|
|
|
|
48 | (4) |
|
|
48 | (1) |
|
|
48 | (2) |
|
|
50 | (1) |
|
|
50 | (1) |
|
|
51 | (1) |
|
Calcium Pyrophosphate Deposition Disease |
|
|
52 | (2) |
|
Epidemiology and Pathophysiology |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
Basic Calcium Phosphate Deposition Disease |
|
|
54 | (1) |
|
|
|
|
54 | (1) |
|
Clinical Manifestations and Physical Examination |
|
|
54 | (1) |
|
Laboratory and Radiographic Studies |
|
|
54 | (1) |
|
|
55 | (2) |
|
Infection with Gram-Positive Organisms |
|
|
55 | (1) |
|
Infection with Gram-Negative Organisms |
|
|
55 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
Prosthetic Joint Infections |
|
|
57 | (1) |
|
Infections in Previously Damaged Joints |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
58 | (1) |
|
Idiopathic Inflammatory Myopathies |
|
|
|
|
58 | (1) |
|
|
58 | (1) |
|
|
59 | (1) |
|
|
59 | (1) |
|
|
59 | (1) |
|
Extramuscular Manifestations |
|
|
59 | (1) |
|
Cardiopulmonary Manifestations |
|
|
60 | (1) |
|
Gastrointestinal Manifestations |
|
|
60 | (1) |
|
|
60 | (1) |
|
|
60 | (1) |
|
|
60 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
62 | (1) |
|
Association with Malignancy |
|
|
62 | (1) |
|
|
62 | (2) |
|
|
|
|
64 | (2) |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
Medium-Sized Vessel Vasculitis |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
67 | (3) |
|
Antineutrophil Cytoplasmic Antibodies and Associated Vasculitis |
|
|
67 | (2) |
|
Cryoglobulinemic Vasculitis |
|
|
69 | (1) |
|
|
69 | (1) |
|
Cutaneous Leukocytoclastic Vasculitis |
|
|
69 | (1) |
|
Other Systemic Inflammatory Diseases |
|
|
|
|
70 | (1) |
|
Clinical Manifestations and Diagnosis |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
72 | (1) |
|
Adult-Onset Still Disease |
|
|
72 | (1) |
|
|
72 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
Familial Autoinflammatory Diseases |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
74 | (1) |
|
|
74 | |
|
|
75 | (1) |
|
|
75 | (1) |
|
|
75 | |
Bibliography |
|
75 | (4) |
Self-Assessment Test |
|
79 | (72) |
Index |
|
151 | |
|
Epidemiology of Cardiovascular Disease |
|
|
|
|
1 | (1) |
|
Ethnicity and Cardiovascular Disease |
|
|
1 | (1) |
|
Chronic Kidney Disease and Cardiovascular Disease |
|
|
2 | (1) |
|
Systemic Inflammatory Conditions and Cardiovascular Disease |
|
|
2 | (1) |
|
Quality Measures in Cardiovascular Disease |
|
|
3 | (1) |
|
Diagnostic Testing in Cardiology |
|
|
|
Clinical History and Physical Examination |
|
|
3 | (1) |
|
Diagnostic Testing for Atherosclerotic Coronary Disease |
|
|
3 | (6) |
|
|
3 | (5) |
|
|
8 | (1) |
|
Visualization of die Coronary Anatomy |
|
|
8 | (1) |
|
Coronary Artery Calcium Scoring |
|
|
8 | (1) |
|
Risks of Coronary Diagnostic Testing |
|
|
8 | (1) |
|
Diagnostic Testing for Structural Heart Disease |
|
|
9 | (2) |
|
Diagnostic Testing for Cardiac Arrhythmias |
|
|
11 | (1) |
|
|
|
Risk Factors for Coronary Artery Disease |
|
|
12 | (2) |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
14 | (5) |
|
|
14 | (1) |
|
|
14 | (3) |
|
Coronary Revascularization |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
19 | (9) |
|
Clinical Presentation and Classification |
|
|
19 | (1) |
|
Non-ST-Elevation Myocardial Infarction and Unstable Angina |
|
|
20 | (2) |
|
ST-Elevation Myocardial Infarction |
|
|
22 | (6) |
|
Coronary Artery Disease in Patients with Diabetes Mellitus |
|
|
28 | (1) |
|
|
28 | (1) |
|
|
29 | (1) |
|
Pharmacologic Treatment and Secondary Prevention |
|
|
29 | (1) |
|
Women and Cardiovascular Disease |
|
|
29 | (1) |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
30 | (1) |
|
|
30 | (1) |
|
|
|
Diagnosis and Evaluation of Heart Failure |
|
|
30 | (2) |
|
|
30 | (1) |
|
|
31 | (1) |
|
|
32 | (1) |
|
|
32 | (1) |
|
Medical Therapy for Systolic Heart Failure |
|
|
32 | (3) |
|
ACE Inhibitors and Angiotensin Receptor Blockers |
|
|
33 | (1) |
|
|
33 | (1) |
|
Initiating and Managing ACE Inhibitor and β-Blocker Therapy |
|
|
34 | (1) |
|
|
34 | (1) |
|
|
34 | (1) |
|
|
34 | (1) |
|
Hydralazine and Isosorbide Dinitrate |
|
|
34 | (1) |
|
|
35 | (1) |
|
Heart Failure With Preserved Ejection Fraction |
|
|
35 | (1) |
|
|
36 | (1) |
|
Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death |
|
|
36 | (1) |
|
Cardiac Resynchronization Therapy |
|
|
36 | (1) |
|
Follow-up Management of Chronic Heart Failure |
|
|
37 | (1) |
|
|
37 | (1) |
|
|
37 | (1) |
|
Inpatient Management of Heart Failure |
|
|
37 | (2) |
|
Acute Decompensated Heart Failure |
|
|
37 | (1) |
|
|
38 | (1) |
|
Strategies to Prevent Readmission |
|
|
39 | (1) |
|
Advanced Refractory Heart Failure |
|
|
39 | (1) |
|
Mechanical Circulatory Support |
|
|
39 | (1) |
|
Management of Posttransplant Patients |
|
|
40 | (1) |
|
Specific Cardiomyopathies |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
Tachycardia-Mediated Cardiomyopathy |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
|
Hypertrophic Cardiomyopathy |
|
|
41 | (5) |
|
Clinical Presentation and Diagnosis |
|
|
41 | (2) |
|
Clinical Course and Risk Stratification |
|
|
43 | (1) |
|
|
43 | (3) |
|
Restrictive Cardiomyopathy |
|
|
46 | (1) |
|
Clinical Presentation and Evaluation |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
Clinical Presentation and Evaluation |
|
|
47 | (1) |
|
|
48 | (1) |
|
|
|
Approach to die Patient with Bradycardia |
|
|
48 | (2) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
Approach to the Patient With Tachycardia |
|
|
50 | (2) |
|
|
50 | (1) |
|
Antiarrhythmic Medications |
|
|
51 | (1) |
|
Atrial Fibrillation and Atrial Flutter |
|
|
52 | (3) |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
53 | (2) |
|
|
55 | (1) |
|
Supraventricular Tachycardias |
|
|
55 | (2) |
|
|
55 | (1) |
|
Atrioventricular Nodal Reentrant Tachycardia |
|
|
56 | (1) |
|
Atrioventricular Reciprocating Tachycardia |
|
|
56 | (1) |
|
Premature Atrial Contractions and Atrial Tachycardia |
|
|
57 | (1) |
|
|
57 | (1) |
|
Premature Ventricular Contractions |
|
|
57 | (1) |
|
Ventricular Tachycardia with Structural Heart Disease |
|
|
57 | (1) |
|
Idiopathic Ventricular Tachycardia |
|
|
57 | (1) |
|
Inherited Arrhythmia Syndromes |
|
|
58 | (2) |
|
|
60 | (1) |
|
|
60 | (1) |
|
|
60 | (1) |
|
Device Therapy for Prevention of Sudden Death |
|
|
61 | (1) |
|
|
61 | (1) |
|
|
|
|
61 | (6) |
|
|
61 | (4) |
|
|
65 | (1) |
|
|
65 | (2) |
|
Pericardial Effusion Without Cardiac Compression |
|
|
67 | (1) |
|
Clinical Presentation and Evaluation |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
68 | (1) |
|
Clinical Presentation and Evaluation |
|
|
68 | (1) |
|
|
68 | (1) |
|
Constrictive Pericarditis |
|
|
69 | (1) |
|
Clinical Presentation and Evaluation |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
|
Pathophysiology of Valvular Heart Disease |
|
|
70 | (1) |
|
|
71 | (4) |
|
History and Physical Examination |
|
|
71 | (1) |
|
Laboratory and Imaging Tests |
|
|
71 | (4) |
|
General Principles of Management of Valvular Disease |
|
|
75 | (2) |
|
|
77 | (1) |
|
Pathophysiology and Natural History |
|
|
77 | (1) |
|
|
77 | (1) |
|
|
78 | (1) |
|
Pathophysiology and Natural History |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
79 | (1) |
|
Pathophysiology and Natural History |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
80 | (1) |
|
Pathophysiology and Natural History |
|
|
80 | (1) |
|
|
80 | (1) |
|
|
80 | (1) |
|
|
81 | (1) |
|
|
81 | (1) |
|
|
82 | (1) |
|
|
82 | (1) |
|
Adult Congenital Heart Disease |
|
|
|
|
83 | (1) |
|
|
83 | (1) |
|
|
84 | (1) |
|
Pathophysiology and Genetics |
|
|
84 | (1) |
|
|
84 | (1) |
|
|
84 | (1) |
|
|
85 | (1) |
|
Reproductive Considerations |
|
|
85 | (1) |
|
Follow-up After Atrial Septal Defect Closure |
|
|
85 | (1) |
|
Ventricular Septal Defect |
|
|
85 | (3) |
|
|
85 | (2) |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
87 | (1) |
|
Reproductive Considerations |
|
|
87 | (1) |
|
Follow-up After Ventricular Septal Defect Closure |
|
|
87 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
89 | (1) |
|
Reproductive Considerations |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
90 | (1) |
|
Reproductive Considerations |
|
|
90 | (1) |
|
Follow-up After Aortic Coarctation Repair |
|
|
90 | (1) |
|
|
90 | (1) |
|
Diagnostic Evaluation after Repair of Tetralogy of Fallot |
|
|
91 | (1) |
|
Treatment of Tetralogy of Fallot Residua |
|
|
91 | (1) |
|
Adults with Cyanotic Congenital Heart Disease |
|
|
91 | (1) |
|
|
91 | (1) |
|
|
92 | (1) |
|
|
|
|
92 | (1) |
|
Imaging of the Thoracic Aorta |
|
|
92 | (1) |
|
|
93 | (2) |
|
|
95 | (1) |
|
|
95 | (1) |
|
|
95 | (1) |
|
|
96 | (1) |
|
Abdominal Aortic Aneurysm |
|
|
96 | (1) |
|
Screening and Surveillance |
|
|
96 | (1) |
|
|
97 | (1) |
|
Peripheral Arterial Disease |
|
|
|
Epidemiology and Screening |
|
|
97 | (1) |
|
|
98 | (1) |
|
History and Physical Examination |
|
|
98 | (1) |
|
|
98 | (1) |
|
|
99 | (1) |
|
Cardiovascular Risk Reduction |
|
|
99 | (1) |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
101 | (1) |
|
Cardiovascular Disease in Cancer Survivors |
|
|
|
Cardiotoxicity of Radiation Therapy to the Thorax |
|
|
102 | (1) |
|
Manifestations and Monitoring of Cardiotoxicity After Completion of Radiation Therapy |
|
|
102 | (1) |
|
Management of Radiation-Induced Coronary Artery Disease |
|
|
102 | (1) |
|
Cardiotoxicity of Chemotherapy |
|
|
103 | (2) |
|
Manifestations and Monitoring of Cardiotoxicity After Completion of Chemotherapy |
|
|
103 | (2) |
|
Management of Chemotherapy-Induced Cardiotoxicity |
|
|
105 | (1) |
|
Pregnancy and Cardiovascular Disease |
|
|
|
Cardiovascular Changes During Pregnancy |
|
|
105 | (1) |
|
|
106 | (1) |
|
Management of Cardiovascular Disease During Pregnancy |
|
|
107 | |
|
Peripartum Cardiomyopathy |
|
|
107 | (1) |
|
Medication Use During Pregnancy |
|
|
107 | (1) |
|
Anticoagulation Therapy During Pregnancy |
|
|
108 | |
Bibliography |
|
111 | (6) |
Self-Assessment Test |
|
117 | (98) |
Index |
|
215 | |
|
Disorders of the Esophagus |
|
|
|
Symptoms of Esophageal Disorders |
|
|
1 | (2) |
|
|
1 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
3 | (1) |
|
|
3 | (1) |
|
Nonmalignant Disorders of the Esophagus |
|
|
3 | (7) |
|
Esophageal Motility Disorders |
|
|
3 | (3) |
|
Infectious, Pill-Induced, and Eosinophilic Esophagitis |
|
|
6 | (1) |
|
Gastroesophageal Reflux Disease |
|
|
7 | (3) |
|
Metaplastic and Neoplastic Disorders of the Esophagus |
|
|
10 | (2) |
|
|
10 | (1) |
|
|
11 | (1) |
|
Disorders of the Stomach and Duodenum |
|
|
|
|
12 | (1) |
|
Clinical Features, Diagnosis, and Complications |
|
|
12 | (1) |
|
|
12 | (1) |
|
|
13 | (1) |
|
|
13 | (1) |
|
|
13 | (1) |
|
Helicobacter pylori Infection |
|
|
13 | (2) |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
Gastrointestinal Complications of NSAIDs |
|
|
15 | (2) |
|
Epidemiology and Risk Factors |
|
|
15 | (1) |
|
Prevention of NSAID-Induced Injury |
|
|
16 | (1) |
|
|
17 | (2) |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
|
Gastric Polyps and Submucosal Lesions |
|
|
19 | (1) |
|
|
19 | (1) |
|
Gastric Subepithelial Masses |
|
|
19 | (1) |
|
|
20 | (1) |
|
Epidemiology and Risk Factors |
|
|
20 | (1) |
|
Screening and Surveillance |
|
|
20 | (1) |
|
Clinical Manifestations and Diagnosis |
|
|
20 | (1) |
|
Complications of Gastric Surgical Procedures |
|
|
20 | (3) |
|
Bariatric Surgery Complications |
|
|
20 | (2) |
|
Other Gastric Resection Complications |
|
|
22 | (1) |
|
Disorders of the Pancreas |
|
|
|
|
23 | (2) |
|
Clinical Presentation and Diagnosis |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
25 | (1) |
|
Clinical Presentation and Diagnosis |
|
|
25 | (1) |
|
|
26 | (1) |
|
Pancreatic Adenocarcinoma |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
27 | (1) |
|
Autoimmune Pancreatitis and IgG4 Disease |
|
|
27 | (1) |
|
Clinical Presentation and Diagnosis |
|
|
28 | (1) |
|
|
28 | (1) |
|
Cystic Neoplasms of the Pancreas |
|
|
28 | (1) |
|
Pancreatic Neuroendocrine Tumors |
|
|
29 | (1) |
|
Disorders of the Small and Large Bowel |
|
|
|
|
30 | (1) |
|
|
30 | (1) |
|
Evaluation and Management |
|
|
30 | (1) |
|
|
31 | (3) |
|
|
31 | (1) |
|
|
32 | (2) |
|
Inflammatory Bowel Disease |
|
|
34 | (5) |
|
|
34 | (1) |
|
|
35 | (1) |
|
Extraintestinal Manifestations |
|
|
36 | (1) |
|
|
36 | (1) |
|
|
37 | (1) |
|
Health Care Maintenance for the Patient with Inflammatory Bowel Disease |
|
|
38 | (1) |
|
|
38 | (1) |
|
|
39 | (2) |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
43 | (2) |
|
Acute Mesenteric Ischemia |
|
|
43 | (1) |
|
Chronic Mesenteric Ischemia |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
|
|
45 | (1) |
|
|
45 | (1) |
|
|
45 | (3) |
|
|
45 | (1) |
|
|
46 | (1) |
|
Nonsyndromic Family History |
|
|
46 | (1) |
|
Hereditary Colorectal Cancer Syndromes |
|
|
46 | (2) |
|
|
48 | (3) |
|
|
48 | (3) |
|
|
51 | (1) |
|
|
51 | (1) |
|
|
51 | (1) |
|
Post-Colorectal Cancer Treatment |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
|
Approach to the Patient with Abnormal Liver Chemistry Studies |
|
|
53 | (1) |
|
|
54 | (3) |
|
|
54 | (1) |
|
|
54 | (1) |
|
|
55 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
Alcohol- and Drug-Induced Liver Disease |
|
|
57 | (1) |
|
Alcohol-Induced Liver Disease |
|
|
57 | (1) |
|
Drug- and Toxin-Induced liver Disease |
|
|
57 | (1) |
|
|
58 | (1) |
|
|
58 | (2) |
|
Nonalcoholic Fatty Liver Disease |
|
|
58 | (1) |
|
Hereditary Hemochromatosis |
|
|
59 | (1) |
|
α1-Antitrypsin Deficiency |
|
|
59 | (1) |
|
|
59 | (1) |
|
Cholestatic Liver Disease |
|
|
60 | (1) |
|
Primary Biliary Cirrhosis |
|
|
60 | (1) |
|
Primary Sclerosing Cholangitis |
|
|
60 | (1) |
|
Complications of Liver Disease |
|
|
61 | (4) |
|
Portal Hypertension and Gastroesophageal Varices |
|
|
61 | (1) |
|
|
62 | (1) |
|
Spontaneous Bacterial Peritonitis |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
64 | (1) |
|
|
64 | (1) |
|
Portopulmonary Hypertension |
|
|
64 | (1) |
|
|
65 | (1) |
|
Fulminant Hepatic Failure |
|
|
65 | (1) |
|
|
66 | (1) |
|
Hepatic Tumors, Cysts, and Abscesses |
|
|
67 | (1) |
|
|
67 | (1) |
|
Focal Nodular Hyperplasia |
|
|
67 | (1) |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
68 | (1) |
|
Pregnancy-Related Liver Disease |
|
|
68 | (1) |
|
Health Care Maintenance of the Patient with Cirrhosis |
|
|
69 | (1) |
|
|
69 | (1) |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
70 | (1) |
|
Vascular Disorders of die liver |
|
|
70 | (1) |
|
|
70 | (1) |
|
|
71 | (1) |
|
Disorders of the Gallbladder and Bile Ducts |
|
|
|
|
71 | (1) |
|
Biliary Colic and Acute Cholecystitis |
|
|
71 | (1) |
|
Epidemiology and Clinical Manifestations |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
72 | (1) |
|
|
72 | (1) |
|
Common Bile Duct Stones and Cholangitis |
|
|
72 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
73 | (1) |
|
Gastrointestinal Bleeding |
|
|
|
|
74 | (1) |
|
Upper Gastrointestinal Bleeding |
|
|
74 | (3) |
|
|
74 | (1) |
|
|
75 | (1) |
|
|
75 | (2) |
|
Lower Gastrointestinal Bleeding |
|
|
77 | (2) |
|
|
77 | (1) |
|
|
77 | (1) |
|
|
78 | (1) |
|
Obscure Gastrointestinal Bleeding |
|
|
79 | |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
80 | |
Bibliography |
|
81 | (4) |
Self-Assessment Test |
|
85 | (70) |
Index |
|
155 | |
|
|
|
Approach to the Patient with Headache |
|
|
1 | (1) |
|
|
1 | (4) |
|
Common Features and Evaluation |
|
|
1 | (2) |
|
|
3 | (1) |
|
Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) |
|
|
4 | (1) |
|
Trigeminal Neuralgia (Tic Douloureux) |
|
|
4 | (1) |
|
|
5 | (5) |
|
|
5 | (4) |
|
|
9 | (1) |
|
|
10 | (1) |
|
Related Primary Headache Syndromes |
|
|
10 | (1) |
|
|
|
|
10 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
Epidural and Subdural Hematoma |
|
|
12 | (1) |
|
Head Injury in a Military Population |
|
|
12 | (1) |
|
|
|
Features and Epidemiology of Epilepsy |
|
|
12 | (1) |
|
Initial Approach to die Patient with a First Seizure |
|
|
13 | (1) |
|
Clinical Presentations of Seizures |
|
|
14 | (1) |
|
|
14 | (1) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
Idiopathic Generalized Epilepsy |
|
|
15 | (1) |
|
Comorbidities and Complications of Epilepsy |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
Sudden Unexplained Death in Epilepsy |
|
|
16 | (1) |
|
Diagnostic Evaluation of Seizures and Epilepsy |
|
|
16 | (2) |
|
|
16 | (1) |
|
|
17 | (1) |
|
Clinical Evaluation and Video Electroencephalographic Monitoring |
|
|
17 | (1) |
|
|
18 | (4) |
|
Antiepileptic Drug Therapy |
|
|
18 | (3) |
|
|
21 | (1) |
|
|
22 | (2) |
|
Generalized Convulsive Status Epilepticus |
|
|
22 | (1) |
|
Nonconvulsive Status Epilepticus |
|
|
22 | (2) |
|
|
|
Epidemiology and Definition of Stroke |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
24 | (4) |
|
Transient Ischemic Attack |
|
|
24 | (2) |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
28 | (4) |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
29 | (3) |
|
|
32 | (1) |
|
|
32 | (1) |
|
|
33 | (1) |
|
|
33 | (3) |
|
Dural Sinus Venous Thrombosis |
|
|
33 | (3) |
|
Carotid and Vertebral Artery Dissection |
|
|
36 | (1) |
|
|
36 | (1) |
|
Admission to Stroke Units and Stroke Centers |
|
|
36 | (1) |
|
Secondary Stroke Prevention |
|
|
36 | (2) |
|
|
36 | (1) |
|
|
36 | (1) |
|
|
37 | (1) |
|
Surgery for Secondary Stroke |
|
|
38 | (1) |
|
Prevention of Stroke Complications |
|
|
38 | (2) |
|
|
38 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
Primary Prevention of Stroke |
|
|
40 | (1) |
|
Asymptomatic Carotid Stenosis |
|
|
40 | (1) |
|
Stroke Recovery and Long-Term Prognosis |
|
|
40 | (1) |
|
|
|
|
40 | (3) |
|
Definition and Description |
|
|
40 | (1) |
|
Evaluation of the Patient with Suspected Dementia |
|
|
41 | (1) |
|
Differential Diagnosis of Dementia |
|
|
42 | (1) |
|
Diagnosis of Alzheimer Diseaseand Other Dementias |
|
|
42 | (1) |
|
|
43 | (2) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
45 | (2) |
|
Dementia with Lewy Bodies |
|
|
45 | (1) |
|
|
46 | (1) |
|
|
46 | (1) |
|
Normal Pressure Hydrocephalus |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
|
Overview of Movement Disorders |
|
|
47 | (1) |
|
|
47 | (4) |
|
Clinical Features of Parkinson Disease |
|
|
48 | (1) |
|
Diagnosis of Parkinson Disease |
|
|
49 | (1) |
|
Treatment of Parkinson Disease |
|
|
49 | (2) |
|
|
51 | (1) |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
|
54 | (1) |
|
Tic Disorders and Tourette Syndrome |
|
|
55 | (1) |
|
|
55 | (1) |
|
Neuroleptic Malignant Syndrome |
|
|
56 | (1) |
|
|
56 | (1) |
|
Multiple Sclerosis and Other Demyelinating Diseases |
|
|
|
Spectrum, Pathophysiology, and Epidemiology |
|
|
57 | (1) |
|
Presenting Signs and Symptoms of Multiple Sclerosis |
|
|
57 | (1) |
|
Diagnosis of Multiple Sclerosis |
|
|
58 | (1) |
|
Diagnostic Criteria and Testing |
|
|
58 | (1) |
|
Differential Diagnosis of Multiple Sclerosis |
|
|
59 | (1) |
|
Clinical Course of Multiple Sclerosis |
|
|
59 | (2) |
|
Treatment of Multiple Sclerosis |
|
|
61 | (3) |
|
Lifestyle Modifications and General Health Care |
|
|
61 | (1) |
|
Treatment of Acute Exacerbations |
|
|
61 | (1) |
|
Disease-Modifying Therapies |
|
|
62 | (1) |
|
|
63 | (1) |
|
Disorders of the Spinal Cord |
|
|
|
Presenting Symptoms and Signs of Myelopathies |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
Noncompressive Myelopathies |
|
|
66 | (2) |
|
Clinical Presentation, Diagnosis, and Management |
|
|
66 | (2) |
|
|
|
|
68 | (5) |
|
|
68 | (1) |
|
Classification, Findings, and Diagnosis |
|
|
68 | (2) |
|
|
70 | (1) |
|
|
70 | (3) |
|
Treatment of Neuropathic Pain |
|
|
73 | (1) |
|
Amyotrophic Lateral Sclerosis |
|
|
73 | (1) |
|
Neuromuscular Junction Disorders |
|
|
74 | (1) |
|
|
74 | (1) |
|
Lambert-Eaton Myasthenic Syndrome |
|
|
74 | (1) |
|
|
75 | (2) |
|
|
75 | (1) |
|
|
76 | (1) |
|
Endocrine-Related Myopathies |
|
|
76 | (1) |
|
|
|
|
77 | (1) |
|
Primary Central Nervous System Tumors |
|
|
78 | (1) |
|
Management of Intracranial Tumors |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
|
|
80 | (1) |
|
|
81 | |
Bibliography |
|
81 | (4) |
Self-Assessment Test |
|
85 | (68) |
Index |
|
153 | |
|
Hematopoietic Stem Cells and Their Disorders |
|
|
|
|
1 | (1) |
|
Bone Marrow Failure Syndromes |
|
|
1 | (4) |
|
|
1 | (2) |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
4 | (1) |
|
The Myelodysplastic Syndromes |
|
|
5 | (1) |
|
Myeloproliferative Disorders |
|
|
6 | (7) |
|
|
6 | (2) |
|
Essential Thrombocythemia |
|
|
8 | (1) |
|
|
8 | (1) |
|
|
9 | (1) |
|
|
10 | (1) |
|
Acute Lymphoblastic Leukemia |
|
|
11 | (1) |
|
Hematopoietic Growth Factors |
|
|
12 | (1) |
|
Hematopoietic Stem Cell Transplantation |
|
|
12 | (1) |
|
Multiple Myeloma and Related Disorders |
|
|
|
|
13 | (1) |
|
|
13 | (3) |
|
Clinical Manifestations and Findings |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
15 | (1) |
|
Monoclonal Gammopathy of Undetermined Significance |
|
|
15 | (1) |
|
Immunoglobulin Light-Chain Amyloidosis |
|
|
16 | (1) |
|
Waldenstrom Macroglobulinemia |
|
|
17 | (1) |
|
|
|
|
18 | (2) |
|
Anemia Due to Erythrocyte Underproduction or Maturation Defects |
|
|
20 | (5) |
|
|
20 | (1) |
|
Cobalamin (Vitamin B12) Deficiency |
|
|
21 | (2) |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
Congenital Hemolytic Anemias |
|
|
26 | (6) |
|
|
26 | (1) |
|
Glucose-6-Phosphate Dehydrogenase Deficiency |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
28 | (3) |
|
|
31 | (1) |
|
Acquired Hemolytic Anemias |
|
|
32 | (3) |
|
Autoimmune Hemolytic Anemia |
|
|
32 | (1) |
|
Warm Autoimmune Hemolytic Anemia |
|
|
32 | (1) |
|
|
32 | (1) |
|
Drug-induced Autoimmune Hemolytic Anemia |
|
|
33 | (1) |
|
Microangiopathic Hemolytic Anemia |
|
|
33 | (1) |
|
Paroxysmal Nocturnal Hemoglobinuria |
|
|
34 | (1) |
|
Other Causes of Hemolysis |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
35 | (1) |
|
|
36 | (1) |
|
|
|
|
36 | (3) |
|
|
36 | (2) |
|
|
38 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
Other Plasma-derived Transfusion Products |
|
|
39 | (1) |
|
Transfusion Complications |
|
|
39 | (2) |
|
|
39 | (1) |
|
|
40 | (1) |
|
Allergic Reactions and Anaphylaxis |
|
|
40 | (1) |
|
Transfusion-associated Graft-Versus-Host Disease |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
41 | (1) |
|
|
|
Overview of Normal Hemostasis |
|
|
42 | (1) |
|
Evaluation of Patients with Suspected Bleeding Disorders |
|
|
42 | (1) |
|
History and Physical Examination |
|
|
42 | (1) |
|
|
43 | (1) |
|
Congenital Bleeding Disorders |
|
|
43 | (3) |
|
|
43 | (2) |
|
|
45 | (1) |
|
Acquired Bleeding Disorders |
|
|
46 | (1) |
|
|
46 | (1) |
|
Coagulopathy of Liver Disease |
|
|
46 | (1) |
|
Disseminated Intravascular Coagulation |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
|
Normal Platelet Physiology |
|
|
47 | (1) |
|
Approach to die Patient with Thrombocytopenia |
|
|
47 | (2) |
|
Immune (Idiopathic) Thrombocytopenic Purpura |
|
|
49 | (1) |
|
Heparin-induced Thrombocytopenia |
|
|
50 | (1) |
|
Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome |
|
|
51 | (1) |
|
Other Thrombocytopenias Due to Underproduction |
|
|
52 | (1) |
|
Qualitative Platelet Disorders |
|
|
52 | (1) |
|
Platelet Function Testing |
|
|
52 | (1) |
|
Acquired Platelet Dysfunction |
|
|
52 | (1) |
|
|
|
Pathophysiology of Thrombosis and Thrombophilia |
|
|
53 | (1) |
|
Inherited Thrombophilic Conditions |
|
|
53 | (1) |
|
|
53 | (1) |
|
Prothrombin G20210A Gene Mutation |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
53 | (1) |
|
|
54 | (1) |
|
Acquired Thrombophilic Conditions |
|
|
54 | (1) |
|
|
54 | (1) |
|
|
54 | (1) |
|
|
54 | (1) |
|
Antiphospholipid Syndrome |
|
|
54 | (1) |
|
Catastrophic Antiphospholipid Syndrome |
|
|
55 | (1) |
|
Other Acquired Thrombophilic Disorders |
|
|
55 | (1) |
|
Management and Prevention |
|
|
55 | (7) |
|
|
55 | (1) |
|
|
56 | (1) |
|
|
56 | (3) |
|
|
59 | (2) |
|
|
61 | (1) |
|
Hematologic Issues in Pregnancy |
|
|
|
|
62 | (1) |
|
|
62 | (1) |
|
|
62 | (1) |
|
|
63 | (1) |
|
Thrombocytopenia in Pregnancy |
|
|
63 | (2) |
|
Gestational Thrombocytopenia |
|
|
63 | (1) |
|
Immune Thrombocytopenic Purpura |
|
|
63 | (1) |
|
Microangiopathy of Pregnancy |
|
|
64 | (1) |
|
Thrombophilia and Venous Thromboembolism in Pregnancy |
|
|
65 | (1) |
|
Epidemiology, Pathophysiology, and Risk Factors |
|
|
65 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
|
|
66 | (1) |
|
|
67 | (2) |
|
|
67 | (1) |
|
|
67 | (1) |
|
|
67 | (1) |
|
Era of Personalized Cancer Treatment |
|
|
68 | (1) |
|
|
|
|
69 | (1) |
|
Epidemiology and Risk Factors |
|
|
69 | (1) |
|
Chemoprevention and Other Risk Reduction Strategies |
|
|
70 | (1) |
|
Primary Breast Cancer Therapy |
|
|
71 | (1) |
|
|
71 | (1) |
|
|
71 | (1) |
|
Adjuvant Systemic Therapy for Early-Stage Breast Cancer |
|
|
72 | (1) |
|
Adjuvant Endocrine Therapy |
|
|
72 | (1) |
|
|
73 | (1) |
|
Locally Advanced and Inflammatory Breast Cancer Therapy |
|
|
73 | (1) |
|
Breast Cancer Follow-up and Survivorship |
|
|
74 | (1) |
|
|
74 | (1) |
|
Ovarian and Cervical Cancer |
|
|
|
|
75 | (3) |
|
Epidemiology and Risk Factors |
|
|
75 | (1) |
|
Screening and Risk Reduction Strategies |
|
|
75 | (1) |
|
|
76 | (1) |
|
|
76 | (1) |
|
Management of Recurrent Ovarian Cancer |
|
|
77 | (1) |
|
|
77 | (1) |
|
|
77 | (1) |
|
|
78 | (1) |
|
Epidemiology and Risk Factors |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
79 | (1) |
|
Gastrointestinal Malignancies |
|
|
|
|
79 | (2) |
|
|
79 | (1) |
|
|
80 | (1) |
|
Postoperative Colorectal Cancer Surveillance |
|
|
81 | (1) |
|
|
81 | (1) |
|
|
81 | (1) |
|
|
82 | (1) |
|
|
83 | (1) |
|
Gastrointestinal Neuroendocrine Tumors |
|
|
83 | (1) |
|
|
|
|
84 | (1) |
|
|
84 | (1) |
|
|
84 | (1) |
|
Non-Small Cell Lung Cancer |
|
|
85 | (2) |
|
|
85 | (1) |
|
|
86 | (1) |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
|
|
88 | (1) |
|
|
88 | (1) |
|
|
89 | (1) |
|
|
|
|
89 | (4) |
|
Epidemiology and Risk Factors |
|
|
89 | (1) |
|
|
90 | (1) |
|
|
90 | (2) |
|
Prostate Cancer Follow-up and Posttreatment Recurrence |
|
|
92 | (1) |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
94 | (1) |
|
|
95 | (1) |
|
|
95 | (2) |
|
|
96 | (1) |
|
|
96 | (1) |
|
Lymphadenopathy and Lymphoid Malignancies |
|
|
|
Epidemiology and Risk Factors of Malignant Lymphomas |
|
|
97 | (1) |
|
Diagnosis of Malignant Lymphomas |
|
|
98 | (1) |
|
Classification, Staging, and Prognosis of Malignant Lymphoma |
|
|
98 | (2) |
|
Overview and Treatment of Indolent Lymphomas |
|
|
100 | (2) |
|
|
100 | (1) |
|
Mucosa-associated Lymphoid Tissue (MALT) Lymphoma |
|
|
101 | (1) |
|
Chronic Lymphocytic Leukemia |
|
|
101 | (1) |
|
|
102 | (1) |
|
Overview and Treatment of Aggressive Lymphomas |
|
|
102 | (2) |
|
Diffuse Large Cell Lymphoma |
|
|
102 | (1) |
|
|
103 | (1) |
|
|
103 | (1) |
|
Cutaneous T-cell Non-Hodgkin Lymphoma |
|
|
104 | (1) |
|
Cancer of Unknown Primary Site |
|
|
|
|
104 | (1) |
|
|
104 | (1) |
|
Favorable Prognostic Subgroups |
|
|
105 | (1) |
|
Poorly Differentiated Carcinoma |
|
|
105 | (1) |
|
Isolated Regional Lymphadenopathy |
|
|
105 | (1) |
|
Peritoneal Carcinomatosis in Women |
|
|
105 | (1) |
|
Management of Patients Not in Favorable Prognosis Subgroups |
|
|
106 | (1) |
|
|
|
|
106 | (1) |
|
Risk Factors and Prognosis |
|
|
106 | (1) |
|
|
106 | (1) |
|
Primary Central Nervous System Tumors |
|
|
107 | (1) |
|
Oncologic Urgencies and Emergencies |
|
|
|
Structural Urgencies and Emergencies |
|
|
107 | (2) |
|
Superior Vena Cava Syndrome |
|
|
107 | (1) |
|
Brain Metastases Causing Increased Intracranial Pressure |
|
|
108 | (1) |
|
|
108 | (1) |
|
Malignant Pleural and Pericardial Effusions |
|
|
108 | (1) |
|
Metabolic Urgencies and Emergencies |
|
|
109 | (1) |
|
|
109 | (1) |
|
|
109 | (1) |
|
Effects of Cancer and Cancer Therapy |
|
|
109 | (2) |
|
|
109 | (1) |
|
Disorders of Cardiac Function |
|
|
110 | (1) |
|
Disorders of Pulmonary Function |
|
|
110 | (1) |
|
Disorders of Genitourinary and Renal Function |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
111 | (1) |
Bibliography |
|
111 | (6) |
Self-Assessment Test |
|
117 | (104) |
Index |
|
221 | |